MINNEAPOLIS, March 5, 2012 /PRNewswire/ -- BioDrain Medical,
Inc. (OTCBB: BIOR, OTCQB: BIOR), producer of the FDA cleared
STREAMWAY System for automated surgical fluid disposal, announced
today that the Company has installed five units of the STREAMWAY
System to fulfill a recent multi-unit purchase order from Unity
Health System, a health care network serving Rochester and western Monroe County, New York.
The order represents long-term as well as short-term revenue
potential, given the consumable revenues attributable to the
purchase of each STREAMWAY unit.
Kevin Davison, CEO of BioDrain,
stated, "We are very excited to announce the installation of these
units and to further tap into the expansive market of hospitals
across the United States. More and
more doctors, surgical personnel and medical staff are being drawn
to STREAMWAY due to its ease of use, important safety, efficiency
and environmental benefits, and exceptional performance in
difficult and high-fluid cases. Accordingly, we are constantly
working to improve our products and technologies, in addition to
ramping-up our production, so we can further establish STREAMWAY
System within the medical device market space. Over 750 surgeries
have already been completed using our STREAMWAY System, and we look
forward to supplying our unique technology to more medical centers
and helping these institutions improve their surgical fluid
handling capabilities in the future."
About BioDrain Medical, Inc.
BioDrain Medical, Inc. has a fully automated, patented, FDA
cleared, surgical fluid disposal system that virtually eliminates
operating room workers' exposure to blood, irrigation fluid and
other potentially infectious fluids found in the surgical
environment. Today's manual surgical fluid handling methods of
hand-carrying filled surgical fluid canisters and emptying these
canisters is an exposure risk and an antiquated approach to the
handling of surgical fluid waste. BioDrain's STREAMWAY System fully
automates the collection, measurement and disposal of surgical
fluids resulting in: 1) reducing overhead costs to hospitals and
surgical centers, 2) improving the Occupational State and Health
Association (OSHA) and other regulatory compliance, and 3)
improving the efficiency of the operating room (and thereby making
surgeries more profitable).
BioDrain's STREAMWAY System is eco-friendly as it contributes to
cleaning up the environment. Currently, approximately 50 million
bloody, potentially disease infected canisters go to landfills
annually in the United States.
These tainted canisters can remain in landfills for years to come.
With the installation of BioDrain's STREAMWAY System, the number of
canisters can be significantly reduced. BioDrain Medical, Inc.
makes the operating room and our environment safer, cleaner, and
better. BioDrain products are currently being represented by
independent professional sales representatives whom cater to the
needs of hospitals and ambulatory surgical centers across the
country. For additional information, please visit:
www.biodrainmedical.com.
Forward-looking Statements:
Certain of the matters discussed in this announcement contain
forward-looking statements that involve material risks to and
uncertainties in the company's business that may cause actual
results to differ materially from those anticipated by the
statements made herein. Such risks and uncertainties include, among
other things, our ability to establish and maintain the proprietary
nature of our technology through the patent process, as well as our
ability to possibly license from others patents and patent
applications necessary to develop products; the availability of
financing; the company's ability to implement its long range
business plan for various applications of its technology; the
company's ability to enter into agreements with any necessary
marketing and/or distribution partners; the impact of competition,
the obtaining and maintenance of any necessary regulatory
clearances applicable to applications of the company's technology;
and management of growth and other risks and uncertainties that may
be detailed from time to time in the company's reports filed with
the Securities and Exchange Commission. This is not a solicitation
to buy or sell securities and does not purport to be an analysis of
the company's financial position. See the company's most recent
Quarterly Report on Form 10-Q and related 8-K filings.
Investor Relations Contact:
Stanley Wunderlich
Consulting for Strategic Growth 1 Ltd.
Tel: 800-625-2236 ext. 7770
Email: info@cfsg1.com
SOURCE BioDrain Medical, Inc.